Pulmonx Corporation provided revenue guidance for the full year 2024 . The company expects revenue for the full year 2024 to be in the range of $81 million to $84 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.08 USD | +0.28% | -3.01% | -44.47% |
Jun. 04 | Lake Street Initiates Pulmonx With Buy Rating, $12 Price Target | MT |
May. 01 | Earnings Flash (LUNG) PULMONX CORPORATION Posts Q1 Revenue $18.9M, vs. Street Est of $17.9M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.47% | 275M | |
+75.69% | 12.57B | |
-21.92% | 7.61B | |
+6.48% | 6.63B | |
+15.67% | 5.53B | |
-15.69% | 4.89B | |
+16.83% | 4.17B | |
-21.75% | 3.99B | |
-23.78% | 2.88B | |
+48.36% | 2.38B |
- Stock Market
- Equities
- LUNG Stock
- News Pulmonx Corporation
- Pulmonx Corporation Provides Revenue Guidance for the Full Year 2024